Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
IPO Year:
Exchange: NASDAQ
Website: trupanion.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $57.00 | Neutral → Overweight | Piper Sandler |
| 7/19/2024 | Outperform | William Blair | |
| 5/16/2024 | $35.00 → $49.00 | Neutral → Buy | BofA Securities |
| 5/8/2023 | $72.00 → $32.00 | Buy → Neutral | BofA Securities |
| 9/21/2022 | $77.00 | Buy | Jefferies |
| 8/4/2022 | $80.00 → $69.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2022 | $129.00 → $118.00 | Neutral → Buy | B of A Securities |
| 12/8/2021 | $126.00 → $183.00 | Overweight | Piper Sandler |
| 11/8/2021 | $112.00 → $129.00 | Buy → Neutral | BofA Securities |
| 10/18/2021 | $112.00 | Buy | BofA Securities |
Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00
William Blair initiated coverage of Trupanion with a rating of Outperform
BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously
BofA Securities downgraded Trupanion from Buy to Neutral and set a new price target of $32.00 from $72.00 previously
Jefferies initiated coverage of Trupanion with a rating of Buy and set a new price target of $77.00
Piper Sandler downgraded Trupanion from Overweight to Neutral and set a new price target of $69.00 from $80.00 previously
B of A Securities upgraded Trupanion from Neutral to Buy and set a new price target of $118.00 from $129.00 previously
Piper Sandler reiterated coverage of Trupanion with a rating of Overweight and set a new price target of $183.00 from $126.00 previously
BofA Securities downgraded Trupanion from Buy to Neutral and set a new price target of $129.00 from $112.00 previously
BofA Securities initiated coverage of Trupanion with a rating of Buy and set a new price target of $112.00